July 2025

9 July 2025

Research Scientist Career at PGIMER - Salary Rs. 67,200 pm

PG degree from a recognized university in Medical Microbiology/ Microbiology/ Virology/ Zoology/ Parasitological/ Genetics/Medical genetics/ Biotechnology/Genomics/Biochemistry with three years post MSc experience or PhD in relevant fields.

9 July 2025

Advertisement for PG in Life Sciences at Manipal Academy of Higher Education

M. Sc. in life science stream with minimum 70% marks. Hands on experience of cell culture; imaging and image analysis; flow cytometry, molecular biology techniques

9 July 2025

Applications are invited for Project Associate at CSMCRI

Selected candidate will work on seaweed culture and cultivation sponsored project, entitled Identification of potential locations across India for seaweed cultivation.

9 July 2025

Intas Pharma hiring Plasma Sourcing Manager - M.Pharm, B.Pharm, MSc Apply

Monitor and analyse market trends, plasma supply-demand dynamics, competitor strategies, and pricing models. Identify new regions and blood banks for plasma collection based on market potential and regulatory compliance.

9 July 2025

Interview for District Sales Manager, Medical Representative at Otsuka Pharma

Min. 7 years experience in Pharma Sales & Min. 1 year experience as a First Line Manager

9 July 2025

Interview for B.Pharm, MSc in ADL, QA, QC at CORONA Remedies

Analytical Method Development, Validation, Transfer activities of test like Assay, RS, Dissolution and Solvent.

9 July 2025

Merck Limited looking for Expert - B.Pharm, M.Pharm Apply

Higher degree in a scientific discipline e.g. computer science, engineering, natural sciences, pharmacy; Merck

9 July 2025

Lupin and Zentiva Sign License and Supply Agreement for Commercializing Certolizumab

Lupin Limited and Zentiva Group , a pan-European pharmaceutical company, have entered into a license and supply agreement for commercialization of Lupins biosimilar Certolizumab Pegol, across multiple markets globally.

9 July 2025

Novartis receives landmark approval for First Malaria Drug for newborns and young infants

In a major breakthrough for global child health, Novartis has received approval from Swissmedic for Coartem Baby, the worlds first malaria treatment specifically developed for newborns and young infants.